News
04-29-2015, 11:51 PM
Blood-based biomarkers such as circulating tumor cells (CTCs), circulating free DNA (cfDNA), circulating tumor DNA (ctDNA) and microRNAs (miRNAs) are potential indicators for the tumor burden of patients living with cancer.
More... (http://www.news-medical.net/news/20150430/CANCER-ID-consortium-aims-to-set-up-standard-procedures-for-clinical-validation-of-blood-based-biomarkers.aspx)
More... (http://www.news-medical.net/news/20150430/CANCER-ID-consortium-aims-to-set-up-standard-procedures-for-clinical-validation-of-blood-based-biomarkers.aspx)